Pdt Partners, LLC Sana Biotechnology, Inc. Transaction History

Pdt Partners, LLC

$1.01 Billion
Q1 2024

A detailed history of Pdt Partners, LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 54,453 shares of SANA stock, worth $297,313. This represents 0.05% of its overall portfolio holdings.

Number of Shares

54,453

Holding current value

$297,313

% of portfolio

0.05%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.2 - $11.27 $228,702 - $613,685	54,453 New	54,453 $544,000
Q3 2023 Nov 14, 2023	SELL	$3.77 - $6.23 $28,930 - $47,809	-7,674 Reduced 28.5%	19,253 $74,000
Q2 2023 Aug 14, 2023	SELL	$3.22 - $7.53 $82,061 - $191,902	-25,485 Reduced 48.62%	26,927 $160,000
Q1 2023 May 15, 2023	SELL	$3.11 - $4.92 $316,047 - $499,985	-101,623 Reduced 65.97%	52,412 $171,000
Q4 2022 Feb 14, 2023	BUY	$3.19 - $6.46 $173,459 - $351,268	54,376 Added 54.56%	154,035 $608,000

Q3 2022 Nov 14, 2022	SELL	$5.58 - $9.04 $290,584 - $470,767	-52,076 Reduced 34.32%	99,659 $598,000
Q1 2022 May 16, 2022	BUY	$5.24 - $15.58 $496,385 - $1.48 Million	94,730 Added 166.18%	151,735 $1.25 Million
Q4 2021 Feb 14, 2022	SELL	$15.18 - $23.15 $252,185 - $384,590	-16,613 Reduced 22.57%	57,005 $882,000
Q3 2021 Nov 15, 2021	BUY	$16.29 - $25.88 $1.2 Million - $1.91 Million	73,618 New	73,618 $1.66 Million

Others Institutions Holding SANA

# of Institutions

156

Shares Held

124M

Call Options Held

297K

Put Options Held

124K

Flagship Pioneering Inc. Cambridge, MA

25M
Shares

$137 Million
16.48% of portfolio
Vanguard Group Inc Valley Forge, PA

12.2M
Shares

$66.4 Million
0.0% of portfolio
Baillie Gifford & CO

10.7M
Shares

$58.2 Million
0.08% of portfolio
Canada Pension Plan Investment Board Toronto Ontario, A6

10.2M
Shares

$55.6 Million
0.11% of portfolio
Black Rock Inc. New York, NY

9.05M
Shares

$49.4 Million
0.0% of portfolio

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $1.04B
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account